Indication

Pediatric and Young Adult Patients with Hypodiploid or t(17;19) B-ALL

1 clinical trial

1 product

Clinical trial

CD19-Directed Chimeric Antigen Receptor CD19 Redirected Autologous T Cells (CART19) for Orphan Indications of Pediatric B Cell Acute Lymphoblastic Leukemia (B ALL)

Status: Recruiting, Estimated PCD: 2028-03-10

Product